This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis Eczema

In brief

This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).

Key facts

Study ID

NCT05935085

Run by

AnaptysBio, Inc.

People needed

201

Starts

2023-06-13

Expected to finish

2025-01-07

Last updated by the study team

2025-02-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• AnaptysBio Investigative Site 10-140 — Anaheim, California, United States
• AnaptysBio Investigative Site 10-141 — Cerritos, California, United States
• AnaptysBio Investigative Site 10-121 — Fountain Valley, California, United States
• AnaptysBio Investigative Site 10-107 — Fremont, California, United States
• AnaptysBio Investigative Site 10-120 — Lancaster, California, United States
• AnaptysBio Investigative 10-125 — Lomita, California, United States
• AnaptysBio Investigative Site 10-146 — Oxnard, California, United States
• AnaptysBio Investigative Site 10-147 — Pasadena, California, United States
• AnaptysBio Investigative Site 10-112 — Santa Monica, California, United States
• AnaptysBio Investigative Site 10-136 — Doral, Florida, United States
• AnaptysBio Investigative Site 10-133 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-116 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-134 — Miami, Florida, United States
• AnaptysBio Investigative Site 10-122 — Atlanta, Georgia, United States
• AnaptysBio Investigative Site 10-130 — Boise, Idaho, United States
• AnaptysBio Investigative Site 10-151 — Flossmoor, Illinois, United States
• AnaptysBio Investigative Site 10-127 — Clarksville, Indiana, United States
• AnaptysBio Investigative Site 10-149 — Merrillville, Indiana, United States
• AnaptysBio Investigative Site 10-128 — New Albany, Indiana, United States
• AnaptysBio Investigative Site 10-137 — Baton Rouge, Louisiana, United States
• AnaptysBio Investigative Site 10-131 — Methuen, Massachusetts, United States
• AnaptysBio Investigative Site 10-126 — Ann Arbor, Michigan, United States
• AnaptysBio Investigative Site 10-139 — Auburn Hills, Michigan, United States
• AnaptysBio Investigative Site 10-114 — Detroit, Michigan, United States
• AnaptysBio Investigative Site 10-106 — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.